期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 60, 期 13, 页码 5638-5645出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.7b00338
关键词
-
资金
- Danish Council for Strategic Research [11-116196]
- University of Southern Denmark
- Lundbeck Foundation
- University of Glasgow
- Lundbeck Foundation [R181-2014-3247] Funding Source: researchfish
The free fatty acid receptor 2 (FFA2/GPR43) is considered a potential target for treatment of metabolic and inflammatory diseases. Here we describe the development of the first fluorescent tracer for FFA2 intended as a tool for assessment of thermodynamic and kinetic binding parameters of unlabeled ligands. Starting with a known azetidine FFA2 antagonist, we used a carboxylic acid moiety known not to be critical for receptor interaction as attachment point for a nitrobenzoxadiazole (NBD) fluorophore. This led to the development of 4 (TUG-1609), a fluorescent tracer for FFA2 with favorable spectroscopic properties and high affinity, as determined by bioluminescence resonance energy transfer (BRET)-based saturation and kinetic binding experiments, as well as a high specific to nonspecific BRET binding signal. A BRET-based competition binding assay with 4 was also established and used to determine binding constants and kinetics of unlabeled ligands.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据